Evidence map›Paper›PMID 37467006›Full record

ArticleCurrent protocols2023

Illuminate the Functions of Dark Proteins Using the Reactome-IDG Web Portal.

Deidre Beavers, Timothy Brunson, Nasim Sanati, Lisa Matthews, Robin Haw, Solomon Shorser, Cristoffer Sevilla, Guilherme Viteri, Patrick Conley, Karen Rothfels and 4 more

Abstract read
In one paragraph

Article in Current protocols, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. The Reactome Pathway Knowledgebase 2024.Nucleic acids research · 2024
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Deidre BeaversOregon Health & Science University, Portland, Oregon.
Timothy BrunsonOregon Health & Science University, Portland, Oregon.
Nasim SanatiOregon Health & Science University, Portland, Oregon.
Lisa MatthewsNYU Langone Health, New York, New York.
Robin HawOntario Institute for Cancer Research, Toronto, Canada.
Solomon ShorserOntario Institute for Cancer Research, Toronto, Canada.
Cristoffer SevillaEuropean Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Hinxton, United Kingdom.
Guilherme ViteriEuropean Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Hinxton, United Kingdom.
Patrick ConleyOregon Health & Science University, Portland, Oregon.
Karen RothfelsOntario Institute for Cancer Research, Toronto, Canada.
Henning HermjakobEuropean Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Hinxton, United Kingdom.
Lincoln SteinOntario Institute for Cancer Research, Toronto, Canada.
Peter D'EustachioNYU Langone Health, New York, New York.
Guanming WuOregon Health & Science University, Portland, Oregon.

Funding

Reactome - CoreU41HG003751 · NHGRI · ONTARIO INSTITUTE FOR CANCER RESEARCH · PI STEIN, LINCOLN D. · 2012 to 2021
$14.5M
Reactome: An Open Knowledgebase of Human Pathways.U24HG012198 · NHGRI · ONTARIO INSTITUTE FOR CANCER RESEARCH · PI Marc E Gillespie, LINCOLN D. STEIN · 2022 to 2026
$7.0M
Reactome IDG portal: Pathway-based analysis and visualization of understudied human proteinsU01CA239069 · NCI · OREGON HEALTH & SCIENCE UNIVERSITY · PI DEUSTACHIO, PETER G, STEIN, LINCOLN D. · 2019 to 2021
$1.3M
NCI NIH HHS U01 CA239069NHGRI NIH HHS U24 HG012198NHGRI NIH HHS U41 HG003751
6 · The paper itself

Abstract

Understudied or dark proteins have the potential to shed light on as-yet undiscovered molecular mechanisms that underlie phenotypes and suggest innovative therapeutic approaches for many diseases. The Reactome-IDG (Illuminating the Druggable Genome) project aims to place dark proteins in the context of manually curated, highly reliable pathways in Reactome, the most comprehensive, open-source biological pathway knowledgebase, facilitating the understanding functions and predicting therapeutic potentials of dark proteins. The Reactome-IDG web portal, deployed at https://idg.reactome.org, provides a simple, interactive web page for users to search pathways that may functionally interact with dark proteins, enabling the prediction of functions of dark proteins in the context of Reactome pathways. Enhanced visualization features implemented at the portal allow users to investigate the functional contexts for dark proteins based on tissue-specific gene or protein expression, drug-target interactions, or protein or gene pairwise relationships in the original Reactome's systems biology graph notation (SBGN) diagrams or the new simplified functional interaction (FI) network view of pathways. The protocols in this chapter describe step-by-step procedures to use the web portal to learn biological functions of dark proteins in the context of Reactome pathways. © 2023 Wiley Periodicals LLC. Basic Protocol 1: Search for interacting pathways of a protein Support Protocol: Interacting pathway results for an annotated protein Alternate Protocol: Use individual pairwise relationships to predict interacting pathways of a protein Basic Protocol 2: Using the IDG pathway browser to study interacting pathways Basic Protocol 3: Overlaying tissue-specific expression data Basic Protocol 4: Overlaying protein/gene pairwise relationships in the pathway context Basic Protocol 5: Visualizing drug/target interactions.

Indexed as

Metabolic Networks and PathwaysSignal TransductionProteinsProteomicsSystems BiologyProteinsdark proteinsdruggable genomeinteracting pathwaysreactometissue-specific expression

Identifiers

PMID37467006
PMCPMC10399304

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.